667, L.P., Director, 10% Owner at ACADIA PHARMACEUTICALS INC (ACAD), bought 1,805,544 shares at $25.65 ($45.6M) on 2023-05-24, disclosed to the SEC on 2023-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.46 | 7,645 | $187K | 0.4% |
| 2 | $24.46 | 82,148 | $2.0M | 4.4% |
| 3 | $24.46 | 82,148 | $2.0M | 4.4% |
| 4 | $24.46 | 7,645 | $187K | 0.4% |
| 5 | $24.80 | 40,632 | $1.0M | 2.2% |
| 6 | $24.80 | 40,632 |
| $1.0M |
| 2.2% |
| 7 | $24.80 | 3,781 | $94K | 0.2% |
| 8 | $24.80 | 3,781 | $94K | 0.2% |
| 9 | $17.01 | 12,500 | $213K | 0.5% |
| 10 | $25.33 | 116,672 | $3.0M | 6.5% |
| 11 | $25.33 | 10,858 | $275K | 0.6% |
| 12 | $25.33 | 116,672 | $3.0M | 6.5% |
| 13 | $25.33 | 10,858 | $275K | 0.6% |
| 14 | $25.54 | 74,582 | $1.9M | 4.2% |
| 15 | $25.54 | 6,941 | $177K | 0.4% |
| 16 | $25.54 | 6,941 | $177K | 0.4% |
| 17 | $25.54 | 74,582 | $1.9M | 4.2% |
| 18 | $25.27 | 218,171 | $5.5M | 12.1% |
| 19 | $25.27 | 218,171 | $5.5M | 12.1% |
| 20 | $25.27 | 20,304 | $513K | 1.1% |
| 21 | $25.27 | 20,304 | $513K | 1.1% |
| 22 | $25.51 | 2,688 | $69K | 0.2% |
| 23 | $25.51 | 2,688 | $69K | 0.2% |
| 24 | $25.51 | 28,878 | $737K | 1.6% |
| 25 | $25.51 | 28,878 | $737K | 1.6% |
| 26 | $25.65 | 24,113 | $618K | 1.4% |
| 27 | $25.65 | 24,113 | $618K | 1.4% |
| 28 | $25.65 | 259,109 | $6.6M | 14.6% |
| 29 | $25.65 | 259,109 | $6.6M | 14.6% |
| Total | $25.27 avg | 1,805,544 | $45.6M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |
| IGMS | BUY | 2022-04-05 | $65.0M | — | Filing → |